All Regulation articles – Page 30
-
Business
Morning sickness drug reintroduced to US
After being withdrawn due to litigation, the drug has been approved by the FDA
-
NewsDrug restrictions delay magic mushroom trial
Illegal drugs red tape holding up clinical research on antidepressant activity of psilocybin
-
Business
European project to boost industry energy efficiency
Initiative will focus on smaller companies and provide tools to assess and reduce energy use
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted
-
Business
Court convicts ex-Aptuit researcher over drug data
Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution
-
Business
Interpol teams up with pharma
Pharmaceutical crime programme will seek to reduce trade in fake drugs
-
Business
Alcohol dependence pill approved in EU
Selincro tablets from Lundbeck designed to reduce consumption of alcohol
-
Business
Merck resolves Vytorin case for $688m
Investors say the company knew about Enhance trial failure but withheld information
-
BusinessReach reviewed: no change required
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
-
Business
DCD in New Zealand milk
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
UK companies struggling with Reach
Regulation is ‘elephant in the room’ as manufacturers fail to recognise implications
-
Business
EPA focuses on five chemicals
Risk assessments for five chemicals put out for public consultation
-
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
Business
Mango and Zara sign up to 'detox' plan
Greenpeace campaign to remove hazardous chemicals from the clothing industry is garnering big name support
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe
-
Business
Bomb chemicals face EU regulation
Retailers say chemical producers and distributors must share regulatory burden
-
Business
Regorafenib approved in US
Stivarga tablets approved for treatment of advanced colorectal cancer
-
BusinessMeasuring nano the European way
Report concludes that companies will need lots of methods to define nanomaterials